PBCM
LLY icon

Point Break Capital Management’s Eli Lilly LLY Stock Holding History

Point Break Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.68M Sell
2,919
-893
-23% -$905K 3.05% 9
2025
Q4 		$4.1M Buy
+3,812
New +$3.64M 3.51% 12
2024
Q3 		$3.74M Sell
4,221
-180
-4% -$162K 4.39% 7
2024
Q2 		$3.98M Buy
4,401
+2,000
+83% +$1.6M 4.33% 5
2024
Q1 		$1.87M Buy
2,401
+1,036
+76% +$737K 1.99% 9
2023
Q4 		$796K Buy
+1,365
New +$797K 0.63% 8

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Point Break Capital Management's LLY Position: Q1 2026 in Review

Point Break Capital Management reduced its Eli Lilly (LLY) stake by 23% in Q1 2026, selling an estimated $905K and leaving 2,919 shares worth $2.68M. The position accounts for 3.05% of the portfolio, ranked #9.

Point Break Capital Management first reported a position in LLY in Q4 2023 and has held it in 6 quarters since. The position peaked at $4.1M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Point Break Capital Management held 2,919 shares of Eli Lilly worth $2.68M as of Q1 2026.
  • Point Break Capital Management sold 893 Eli Lilly shares in Q1 2026, an estimated $905K.
  • Eli Lilly made up 3.05% of Point Break Capital Management's portfolio in Q1 2026, its #9 holding.
  • Point Break Capital Management first reported a position in Eli Lilly in Q4 2023 and has held it in 6 quarters since.
  • Point Break Capital Management's Eli Lilly position peaked at $4.1M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Point Break Capital Management's 13F filing for Q1 2026, filed 14 May 2026.